Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Endocrinology
•
Bone and Calcium Disorders
How do you approach treatment of low bone density in very young women with longstanding functional hypothalamic amenorrhea?
Related Questions
Following abaloparatide use for osteoporosis treatment, how long do you consolidate with bisphosphonates before considering a drug holiday?
Would you consider exploratory surgery in a young patient with normocalcemic hyperparathyroidism that meets one or more criteria for parathyroidectomy but has no localized pathology on advanced neck imaging?
When is it safe to start or resume bisphosphonate therapy in patients with a history of osteonecrosis of the jaw that is unrelated to osteoporosis treatment?
Would you transition from denosumab to anabolic agents in patients who are in urgent need for extensive dental work?
Would you stop denosumab in a patient with chronic kidney disease if they develop asymptomatic hypocalcemia after the injection?
How do you monitor patients with Paget’s disease with normal serum alkaline phosphatase?
Can joint replacement surgery be performed in someone with active Paget’s disease elsewhere?
What is your approach to managing osteoporosis in patients with end stage kidney disease?
How do you distinguish between primary and tertiary hyperparathyroidism in a patient with ESRD?
Would you start anabolic agents for osteoporotic hip fracture healing?
